2. PROTAC Cell Cycle/DNA Damage Apoptosis
  3. PROTACs Checkpoint Kinase (Chk) DNA/RNA Synthesis Apoptosis Bcl-2 Family Caspase
  4. MA203

MA203 is a highly efficient and selective PROTAC degrader targeting CHK1. MA203 accelerates CRBN-dependent proteasomal degradation of CHK1 in solid tumor-derived cells and acute leukemia cells. MA203 induces DNA replication stress. MA203 blocks cell cycle progression and triggers tumor cell apoptosis. MA203 does not damage healthy differentiated and primitive hematopoietic cells, stromal cells, and retinal epithelial cells. MA203 can be used for the study of CHK1-dependent cancers.
(Pink: Chk1 Target protein ligand; Blue: Cereblon ligand (HY-41547); Black: linker (HY-22391)).

For research use only. We do not sell to patients.

MA203

MA203 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

MA203 Related Antibodies

Top Publications Citing Use of Products

View All PROTACs Isoform Specific Products:

View All Isoforms
von Hippel-Lindau (VHL) Cereblon MDM2 cIAP1

View All Checkpoint Kinase (Chk) Isoform Specific Products:

View All Isoforms
Chk1 Chk2 BUBR1

View All Bcl-2 Family Isoform Specific Products:

View All Isoforms
Bcl-2 Bcl-xL Bcl-W Mcl-1 Bfl-1 Bcl-B Bax Bak Bim BNIP3

View All Caspase Isoform Specific Products:

View All Isoforms
Caspase 1 Caspase 2 Caspase 3 Caspase 4 Caspase 5 Caspase 6 Caspase 7 Caspase 8 Caspase 9 Caspase 10 Caspase 12 Caspase Caspase 11 Caspase-13

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

MA203 is a highly efficient and selective PROTAC degrader targeting CHK1. MA203 accelerates CRBN-dependent proteasomal degradation of CHK1 in solid tumor-derived cells and acute leukemia cells. MA203 induces DNA replication stress. MA203 blocks cell cycle progression and triggers tumor cell apoptosis. MA203 does not damage healthy differentiated and primitive hematopoietic cells, stromal cells, and retinal epithelial cells. MA203 can be used for the study of CHK1-dependent cancers[1]. (Pink: Chk1 Target protein ligand; Blue: Cereblon ligand (HY-41547); Black: linker (HY-22391)).

IC50 & Target[1]

Chk1

 

Bax

 

Bcl-xL

 

In Vitro

MA203 (PROTAC 41) reduces CHK1 levels by ∼50% at 5 µM in MIA PaCa-2 pancreatic ductal adenocarcinoma (PDAC) cells and binds avidly to CHK1 (97% binding at 1.0 µM)[1].
MA203 (2 µM, 24 h) highly significantly attenuates CHK1 levels by up to 80% and 50% in Hydroxyurea (HY-B0313) (HU)-treated MIA PaCa-2 and MOLT-4 cells[1].
MA203 (2 μM, 3-24 h)-mediated CHK1 degradation is a time-dependent event accompanied by changes in phosphorylation state in MIA PaCa-2 cells, indicating that degradation enhances DNA damage signals[1].
MA203 plus HU reduces CHK1 significantly to 50 %-40 % of its levels in untreated cells in MOLT-4 cells, MOLM-13 cells, RS4-11 cells, HCT116 cells and attenuates CHK1 levels in MOLM-13 cells[1].
MA203 (1-5 µM, 24 h) dose-dependently attenuates CHK1 more efficiently when combined with 5 µM Irinotecan (HY-16562) than when used alone in MIA PaCa-2 cells[1].
MA203 (0.5-10 µM, 24 h) exhibits a significantly lower concentration for half-maximum CHK1 degradation when combined with 2 µM Cytarabine (HY-13605) (DC50 = 387.4 nM) than when used alone (DC50 = 3.86 µM) in MOLT-4 cells[1].
MA203 (0.5–10 μM, 24 h) enhances HU-induced DNA replication stress, leading to DNA double-strand breaks and replication catastrophe in MIA PaCa-2 and MOLT-4 cells[1].
MA203 (2 μM, 24-48 h) + HU significantly increases the proportion of cells undergoing early and late apoptosis in MIA PaCa-2 and MOLT-4 cells[1].
MA203 (2 µM, 24 h) alone and in combination with HU promotes the viability of dendritic cells[1].
MA203 (2 µM, 24 h) substantially augments Ara-C-mediated cell death, evidenced by a 62% decrease in the Ara-C concentration needed to kill 50% of MOLT-4 cells (IC50) in MOLT-4 cells[1].
MA203 (2 µM, 24 h) + HU for 24 h yields a unique and obvious reduction of several key proteins that control tumorigenesis and DNA damage repair, including transcription factor-7 (TCF7), cell division cycle-associated-7 (CDCA7), origin recognition complex subunit-1 (ORC1), and Werner syndrome RecQ-like helicase (WRN) and weakly augmented RRM2 levels in MIA PaCa-2 cells[1].
MA203 (2 µM, 24-48 h) + HU leads to stronger G1/S phase arrest; induces a higher apoptosis rate, accompanied by upregulation of BAX/BIM and downregulation of BCL-XL/XIAP; more significant loss of mitochondrial membrane potential and stronger caspase activation in MIA PaCa-2 cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

MA203 Related Antibodies

Western Blot Analysis[1]

Cell Line: MIA PaCa-2 cells, MOLT-4 cells
Concentration: 2 µM
Incubation Time: 24 h
Result: Specifically degraded CHK1, and this degradation is enhanced by HU-induced CHK1 activation.
Did not affect other checkpoint kinases or common CRBN substrates.

Western Blot Analysis[1]

Cell Line: MIA PaCa-2 cells
Concentration: 2 µM
Incubation Time: 3 h, 6 h, 10 h, 16 h, 24 h
Result: Illustrated that the degradation of CHK1 started already after 3 h in MIA PaCa-2 cells, to yield a 50%-70% reduction of CHK1 after 10-16 h.
Suppressed the HU-induced hyperphosphorylation of CHK1 at S296 but augmented its HU-induced hyperphosphorylation at S345.
Did not alter CHK2 levels over different time points.

Western Blot Analysis[1]

Cell Line: MIA PaCa-2, MOLT-4
Concentration: 0.5 μM, 1 μM, 2 μM, 5 μM, 10μM
Incubation Time: 24 h
Result: Significantly increased γH2AX levels (4.2-fold).
Achieved a Dmax of 92% at a DC50 of 1.51 µM in MIA PaCa-2 cells, and a Dmax of 93.2% at a DC50 of 5.35 µM in MOLT-4 cells.
Significant 15.7-fold induction of ATM phosphorylation at S1981.

Apoptosis Analysis[1]

Cell Line: MIA PaCa-2 cells, HCT116 cells, MOLT-4 cells, MOLM-13 cells
Concentration: 2 μM
Incubation Time: 24 h, 48 h
Result: After 48 h, the percentages of early and late apoptotic cells significantly increased to 15% and 14% in MIA PaCa-2 cell cultures; A significant rise in the early apoptotic cell population to 33% was observed.
In HCT116 cells, caused early and late apoptosis were significantly increased when combined with 0.5 mM HU for 48 h. An accumulation of late apoptotic cells (30%) occurred upon treatment.
Significantly augmented cell populations in early apoptosis to 19% and in late apoptosis to 15% after 24 h in MOLT-4 cells. In the presence of 1 mM HU, triggered early (48%) and late (24%) apoptotic cell death.
In MOLM-13 cells, triggered a significant accumulation of early apoptotic cells (33%), enhanced late apoptosis of MOLM-13 cells to 50%.
Normal human cells did not exhibit any significant impairment in viability upon treatment.
In Vivo

MA203 (PROTAC 41) (12 μM, 48 h) significantly inhibits the proliferation of human leukemia cells in zebrafish larvae, and shows no significant toxicity to zebrafish larvae at effective doses[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Molecular Weight

755.82

Formula

C38H45N9O8
SMILES

O=C1CCC(N2C(C(C=CC=C3NCCCCCCCNC(C4=CC(OC[C@H]5OCCNC5)=C(NC(NC6=CN=C(C)C=N6)=O)C=C4)=O)=C3C2=O)=O)C(N1)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

MA203 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

MA203MA 203MA-203PROTACsCheckpoint Kinase (Chk)DNA/RNA SynthesisApoptosisBcl-2 FamilyCaspaseRPOTACCHK1CereblonMIA PaCa-2 cellsMOLT-4MOLM-13RS4-11Inhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
MA203
Cat. No.:
HY-179157
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.